a nonsignificant trendp = 0.052
Among treatment modalities, BTKi therapy showed a nonsignificant trend toward improved survival compared to other approaches (HR 0.29, 95% CI 0.08–1.01, p = 0.052, Table 3 ), though this finding should be interpreted cautiously given the relatively small number of patients treated with this class of agents.